These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6306938)

  • 1. [Inhibition of acetylcholinesterases--a relevant side effect of ranitidine?].
    Hansen WE; Bertl S
    Z Gastroenterol; 1983 Apr; 21(4):164-7. PubMed ID: 6306938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of acetylcholinesterase and pseudocholinesterase by cimetidine.
    Hansen WE; Bertl S
    Arzneimittelforschung; 1983; 33(1):161-3. PubMed ID: 6681969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of cholinesterases by histamine 2 receptor antagonist drugs.
    Laine-Cessac P; Turcant A; Premel-Cabic A; Boyer J; Allain P
    Res Commun Chem Pathol Pharmacol; 1993 Feb; 79(2):185-93. PubMed ID: 8095733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of ranitidine.
    Petroianu GA; Arafat K; Schmitt A; Hasan MY
    J Appl Toxicol; 2005; 25(1):60-7. PubMed ID: 15669026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of ranitidine therapy.
    Cleator IG
    Can Med Assoc J; 1983 Sep; 129(5):405. PubMed ID: 6309353
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of AChE by single and simultaneous exposure to malathion and its degradation products.
    Krstić D; Colović M; Krinulović K; Djurić D; Vasić V
    Gen Physiol Biophys; 2007 Dec; 26(4):247-53. PubMed ID: 18281741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine.
    Petroianu GA; Hasan MY; Nurulain SM; Shafiullah M; Sheen R; Nagelkerke N
    Basic Clin Pharmacol Toxicol; 2006 Oct; 99(4):312-6. PubMed ID: 17040217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of cimetidine and ranitidine on drug metabolism of the liver].
    Homann J; Paul F; Kratz F; Leimenstoll G; Kamenisch W; Matthes KJ
    Med Welt; 1983 Mar; 34(10):313-5. PubMed ID: 6302436
    [No Abstract]   [Full Text] [Related]  

  • 9. Mental confusion associated with ranitidine.
    Hughes JD; Reed WD; Serjeant CS
    Med J Aust; 1983 Jul; 2(1):12-3. PubMed ID: 6306415
    [No Abstract]   [Full Text] [Related]  

  • 10. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
    Petroianu GA; Hasan MY; Arafat K; Nurulain SM; Schmitt A
    J Appl Toxicol; 2005; 25(6):562-7. PubMed ID: 16193528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ranitidine or nocloprost on the selected gastric juice components in the patients with the gastric ulcer.
    Skrodzka D; Gabryelewicz A
    Rocz Akad Med Bialymst; 1997; 42(1):257-66. PubMed ID: 9581490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
    Lanza F; Goff J; Scowcroft C; Jennings D; Greski-Rose P
    Am J Gastroenterol; 1994 Aug; 89(8):1191-200. PubMed ID: 8053433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weak inhibitors protect cholinesterases from stronger inhibitors (dichlorvos): in vitro effect of tiapride.
    Petroianu GA; Schmitt A; Arafat K; Hasan MY
    Int J Toxicol; 2005; 24(2):79-86. PubMed ID: 16036766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
    Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
    Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the damaging effects of acetazolamide on gastric mucosa in rats.
    Cho CH; Pfeiffer CJ
    Acta Physiol Hung; 1984; 64(3-4):279-85. PubMed ID: 6442531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyryl- and acetyl-cholinesterase inhibitory activities in essential oils of Salvia species and their constituents.
    Savelev SU; Okello EJ; Perry EK
    Phytother Res; 2004 Apr; 18(4):315-24. PubMed ID: 15162368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relevant inhibition of acetylcholinesterase with H2-receptor antagonists].
    Jensen JC; Gugler R
    Z Gastroenterol; 1984 Mar; 22(3):109-12. PubMed ID: 6326400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intermittent feed deprivation, intermittent feed deprivation with ranitidine administration, and stall confinement with ad libitum access to hay on gastric ulceration in horses.
    Murray MJ; Eichorn ES
    Am J Vet Res; 1996 Nov; 57(11):1599-603. PubMed ID: 8915437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
    Amagase K; Kato S; Yamamoto H; Okabe S
    Arzneimittelforschung; 1996 Feb; 46(2):177-84. PubMed ID: 8720310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.